CN101780254B - Traditional Chinese medicine compound for treating intestinal tumor - Google Patents

Traditional Chinese medicine compound for treating intestinal tumor Download PDF

Info

Publication number
CN101780254B
CN101780254B CN2010101153557A CN201010115355A CN101780254B CN 101780254 B CN101780254 B CN 101780254B CN 2010101153557 A CN2010101153557 A CN 2010101153557A CN 201010115355 A CN201010115355 A CN 201010115355A CN 101780254 B CN101780254 B CN 101780254B
Authority
CN
China
Prior art keywords
parts
chinese medicine
rhizoma
radix
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010101153557A
Other languages
Chinese (zh)
Other versions
CN101780254A (en
Inventor
王峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Original Assignee
Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd filed Critical Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Priority to CN2010101153557A priority Critical patent/CN101780254B/en
Publication of CN101780254A publication Critical patent/CN101780254A/en
Application granted granted Critical
Publication of CN101780254B publication Critical patent/CN101780254B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a new traditional Chinese medicine compound for treating intestinal tumor and a preparation method thereof, wherein the traditional Chinese medicine compound of the invention mainly comprises the following raw material medicines: fried pangolin, fried frankincense, fried myrrh, rhizoma sparganii, rhizoma zedoariae, trichosanthes root, dried orange peel, elecampane, peach kernel, safflower, stir-fried maticated leaven, amomum villosum, yam, woodlouse, angelica, fried turtle shell, fried tortoise plastron, rhizoma ligustici wallichii, aspongopus, rhizoma atractylodis, magnolia officinalis and the like. The traditional Chinese medicine compound of the invention can be prepared into any common oral preparation according to a conventional traditional Chinese medicine preparation method. The invention can markedly improve the symptoms of carreau, abdominal pain, diarrhea, inappetence, intestinal bleeding, hematochezia or pyoid stool and the like, and has exact clinical curative effect, remarkable curative effect and rapid effect taking. Because the traditional Chinese medicine compound of the invention is combined by basically adopting medicine-food homologous medicaments specified in National Formulary, the traditional Chinese medicine compound has the advantages of low cost, basically no toxic or side effect and the like.

Description

A kind of Chinese medicine composition for the treatment of intestinal tumour
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of intestinal tumour.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment intestinal tumour of crude drug with the Chinese herbal medicine.
Background technology
Intestinal tumour is meant the Liang ﹑ malignant tumor that betides small intestinal and large intestine.Clinical manifestation is different because of tumorigenic character and position.In general, benign tumor can be asymptomatic or symptom is very light, and the malignant tumor that has is also non-evident sympton in early days.Lump is can the general activity degree not bigger in the abdomen
Figure DEST_PATH_IMAGE001
How unfixing the position is, follows stomachache, diarrhoea
Figure DEST_PATH_IMAGE002
Clinical symptoms such as inappetence, intestinal bleeding, the severe patient acute perforation causes peritonitis
Figure DEST_PATH_IMAGE001A
Chronic medicine perforation then forms intestinal fistula, threat to life, and the clinical onset rate has the trend of continuous rising in recent years.
The cause of disease of intestinal tumour is unclear so far, modern medicine affects the state of an illness adversely, in order to overcome above-mentioned defective lacking effective measures and way aspect prevention and the treatment intestinal tumour, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment intestinal tumour, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of strengthening the body resistance, hard masses softening and resolving, diffusing swollen toxin expelling, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment intestinal tumour that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment intestinal tumour of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of intestinal tumour of the present invention, the component of main following weight portion is formed:
1~100 part of Squama Manis (processed), 1~50 part of Olibanum (processed), 1~50 part of Myrrha (processed), 1~300 part of Semen Coicis, 1~150 part in Poria, 1~50 part of rhizoma sparganic, 1~50 part of Rhizoma Curcumae, 1~100 part of Radix Trichosanthis, 1~60 part of Rhizoma Coptidis, 1~50 part of Hirudo, 1~100 part of Radix Notoginseng, 1~100 part of Radix Sophorae Flavescentis, 1~120 part of Herba Taraxaci, 1~60 part of Herba Andrographis, 1~100 part of Indigo Naturalis, 1~100 part of Cortex Moutan, 1~150 part of Pericarpium Citri Reticulatae, 1~120 part of the Radix Aucklandiae, 1~150 part of Rhizoma Cyperi, 1~150 part of the Radix Paeoniae Alba, 1~120 part of Platycladi Cacumen carbonisatum, 1~150 part of Radix Et Rhizoma Rhei, 1~100 part of Semen Pruni, 1~50 part in Semen Persicae, 1~50 part on Flos Carthami, 1~300 part of Massa Medicata Fermentata preparata, 1~150 part of Fructus Hordei Germinatus (parched), 1~100 part of Semen Arecae (parched), 1~120 part of Eupolyphaga Seu Steleophaga, 1~50 part of Herba Eupatorii, 1~100 part of Fructus Amomi, 1~100 part of the Rhizoma Atractylodis Macrocephalae, 1~140 part of Rhizoma Dioscoreae, 1~120 part of Pheretima, 1~300 part of Radix Angelicae Sinensis, 1~100 part of Radix Codonopsis, 1~120 part of Radix Rehmanniae Preparata, 1~100 part of Carapax Trionycis (processed), 1~100 part of Carapax Et Plastrum Testudinis (processed).
Be preferably:
30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Herba Taraxacis, 20 parts of Herba Andrographis, 20 parts of Indigo Naturaliss, 20 parts of Cortex Moutans, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 30 parts of Fructus Hordei Germinatus (parched)s, 20 parts of Semen Arecae (parched)s, 20 parts of Eupolyphaga Seu Steleophagas, 15 parts of Herba Eupatoriis, 20 parts of Fructus Amomis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Rhizoma Dioscoreaes, 20 parts of Pheretimas, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed).
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1~50 part of Flos Caryophylli, 1~50 part in Pericarpium Zanthoxyli, 1~100 part in Rhizoma Zingiberis Recens, 1~120 part of Semen Raphani, 1~120 part of Aloe, 1~100 part in Radix Rubiae, 1~50 part of Rhizoma Atractylodis, 1~120 part of Cortex Magnoliae Officinalis, 1~30 part in Lignum Santali Albi, 1~100 part of the Radix Linderae, 1~100 part of Aspongopus, 1~120 part of Endothelium Corneum Gigeriae Galli, 1~100 part of Pollen Typhae, 1~120 part of Lignum Dalbergiae Odoriferae, 1~100 part of Pseudobulbus Bletillae (Rhizoma Bletillae), 1~120 part of Rhizoma Chuanxiong, 1~100 part of Semen Plantaginis, 1~60 part of Rhizoma Alismatis, 1~120 part of Fructus Lycii, 1~50 part of Herba Pogostemonis, 1~50 part of Fructus Tsaoko, 1~100 part in Rhizoma Curcumae Longae, 1~120 part of Semen Vaccariae, 1~50 part of Lignum Sappan, 1~100 part of charred Radix Sanguisorbae, 1~120 part of the Fructus Sophorae.
Be preferably:
10 parts of Flos Caryophyllis, 15 parts in Pericarpium Zanthoxyli, 20 parts in Rhizoma Zingiberis Recens, 30 parts of Semen Raphanis, 20 parts of Aloes, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 15 parts in Lignum Santali Albi, 30 parts of the Radixs Linderae, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Pollen Typhaes, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of Semen Plantaginiss, 15 parts of Rhizoma Alismatis, 30 parts of Fructus Lyciis, 15 parts of Herba Pogostemoniss, 15 parts of Fructus Tsaokos, 15 parts in Rhizoma Curcumae Longae, 20 parts of Semen Vaccariae, 15 parts of Lignum Sappans, 20 parts of charred Radix Sanguisorbae, 20 parts of the Fructuss Sophorae.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2~5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2~4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 3~5 grams, warm water takes.4) granule: every day three times.Each 3~5 grams, warm water takes.5) powder: every day three times, each 2~4 grams, warm water takes.
The treatment that the present invention is directed to the intestinal tumour patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 20 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Amomis, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed), 30 parts of Semen Raphanis, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of charred Radix Sanguisorbae.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 20 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Amomis, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed), 30 parts of Semen Raphanis, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of charred Radix Sanguisorbae.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material according to following weight portion: 30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 20 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Amomis, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed), 30 parts of Semen Raphanis, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of charred Radix Sanguisorbae.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800~1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material according to following weight portion: 30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 20 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Amomis, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed), 30 parts of Semen Raphanis, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of charred Radix Sanguisorbae.
Each raw material of above-mentioned weight is mixed, grind into cross 600~1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material according to following weight portion: 30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 20 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Amomis, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed), 30 parts of Semen Raphanis, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of charred Radix Sanguisorbae.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into rule
Fixed concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating intestinal tumour of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 63 routine patients altogether, wherein male 38 examples, women 25 examples; The oldest person 79 years old, the age reckling has only 35 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2~5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2~4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 3~5 grams, warm water takes.4) granule: every day three times.Each 3~5 grams, warm water takes.5) powder: every day three times, each 2~4 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 12 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: the tumor body disappears, and sign and symptom are improved fully, and diet and stool are normal, happy, in high spirits.
Produce effects: the tumor body significantly dwindles, and sign and symptom are improved substantially, and diet and stool are normal, and spirit takes a turn for the better.
Effectively: the tumor body reduces to some extent, and sign and symptom have improvement.
Invalid: sign does not have any change, symptom such as preceding.
Four, model case:
1, Zou so-and-so, man, 42 years old, engineer.
The patient felt that before February stool is unfavorable, relieving constipation medicine commonly used is to alleviate, after then take place to expand weigh down, reuse Chinese medicine and Western medicine laxative are all ineffective, go out owing to weigh down the difficulty that expands, must be logical with the enema stool beginning, after proctoscopy, find that rectum epimere and sigmoid colon intersection have the lump of an Ovum Anas domestica size, are diagnosed as the rectum tumor.Through treating with the antitumor drug thing, effect does not show to come prescription on individual diagnosis.Be severe disease and hold, main painful expanding in stool weighed down difficult logically, examines deep and stringy pulse and delay, and be as usual to counting, spiritual diet still can, tongue fur is thick in vain, emaciated physique.
Took Chinese medicine composition of the present invention 15, stool can solve automatically, knows hungry can the food, only is with blood just the time, and took Chinese medicine composition of the present invention again 1 month, proctoscopy: lump is more preceding significantly to be reduced, and defecates hemorrhagely to end, and it is thirsty to show dry tongue.The clothes Chinese medicine composition of the present invention 3 months that continues, proctoscopy: lump reduces to preceding 1/2 size approximately, diet still can, not bitterly, weigh down bloated alleviating in the abdomen.Continue and obeyed Chinese medicine composition of the present invention 6 months, proctoscopy: lump disappears substantially, and symptom all disappears, and follows up a case by regular visits to so far, and rehabilitation is as usual, adheres to working work.
2, Zhang, man, 56 years old, driver.
The patient feels uncomfortable October calendar year 2001, and times of defecation increases, and feces attenuates, the sticking blood of band, have defecation to feel not to the utmost, November 4 went to see a doctor, by rectal touch, and endorectal ultrasound scanning, find lump, do pathological changes tissue pathology checking, be diagnosed as the rectum tumor, 7.6 * 6.5cm.Begin to accept radiotherapy November 15 calendar year 2001, reacts too strong in the radiotherapy process, once once ended.
Took Chinese medicine composition of the present invention 1 month, focus size 6.1 * 4.9cm, times of defecation reduces, remission.Obeyed Chinese medicine composition of the present invention 3 months, focus size 4.6 * 3.2cm, the accidental band of defecating glues blood, and symptom is greatly taken on a new look.The clothes Chinese medicine composition of the present invention 5 months that continues is surplus, and focus disappears substantially, and the patient gets well, and does not have uncomfortable symptom, follows up a case by regular visits to and does not see recurrence so far.
3, Zhang, man, 62 years old, retired worker.
Medical history: go to a doctor in certain hospital because of 2 weeks of having blood in stool in November, 1999, and per rectum refers to inspections such as inspection, romanoscope, CT, and colonoscope sees that there is 2cmX3cm at the rectum place, big or small obscure boundary ulcer, the visible rotten to the corn hemorrhage lump in surface; CT does not see regional glandular enlargement.Be diagnosed as the rectum tumor, the row operation.The capable local radiotherapy of postoperative and 3 courses of treatment of systemic chemotherapy.Disease is seen: dizzy and heavy, idol has the left hand numbness, moving then cardiopalmus, and the poor appetite gastral cavity is bloated.Tongue is dim red, yellow and greasy fur, stringy and rolling pulse.
Took Chinese medicine composition of the present invention 1 month, focus 1.5cmX2cm, cardiopalmus is fixed, and surplus disease is gradually slow.Continue and obeyed Chinese medicine composition of the present invention 3 months, focus disappears substantially, band blood during idol has just, and diet increases, and malaise symptoms disappears substantially, and symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 5 months, do not see focus, every inspection is all normal, follows up a case by regular visits to so far, and situation is stable.
4, Lee so-and-so, man, 38 years old, cadre.
The patient abdominal pain diarrhea often occurs in December, 2005, by general enteritis treatment, does not feel any better in 3 months.There is one day accidental abdominal part left side of touching that obvious lump is arranged, about egg size, hard painless.Do super inspection of B and be found to be substantive enclosed mass, examine and be intestinal canal tumour.
Took Chinese medicine composition of the present invention 1 month, focus is significantly less, and abdominal pain diarrhea alleviates.Continue and obeyed Chinese medicine composition of the present invention 3 months, focus is more preceding significantly to be reduced, and abdominal pain diarrhea stops, and malaise symptoms disappears substantially, and symptom is greatly taken on a new look.The clothes Chinese medicine composition of the present invention that continues is surplus June, foci disappearance, and every inspection is all normal, recovers operate as normal, does not see recurrence so far.
5, Yao, woman, 62 years old, retired worker.
Abdominal distention stomachache repeatedly at the beginning of 5 months, idol has constipation, once arrive how tame hospital admission, is diagnosed as " intestinal obstruction ", " unknown origin ", and row CT, inspection such as ultrasonic still can't be made a definite diagnosis, in hospital the expectant treatment poor effect.After forward the 3rd department of general surgery of Affiliated Hospital of Nanfang Medical Univ to, be admitted to hospital with " intestinal obstruction look into because of ".The consultation of doctors and full section are discussed repeatedly in institute, think this patient advanced age, state of an illness complexity, critical, for patient's row exploratory laparotomy, make a definite diagnosis: intestinal canal tumour.
Took Chinese medicine composition of the present invention 1 month, abdominal distention stomachache alleviates.Continue and obeyed Chinese medicine composition of the present invention 3 months, abdominal pain and distension continues to alleviate, and constipation ends, and malaise symptoms disappears substantially, and symptom is greatly taken on a new look.The clothes Chinese medicine composition of the present invention that continues is surplus June, transference cure, and patient health, movable as usual, do not see recurrence so far with examining.
6, Wu, woman, 47 years old, teacher.
The main suit: abdominal distention is surplus January of becoming thin.Played abdominal distention before 1 month, weak, carrying out property increases the weight of, and it is poor to take food, and oliguria is become thin about 20 jin, row's mucus hemafecia.Intestinal mirror, CT: the inferior mesenteric artery radiography, rectum has lump, diagnosis: rectal neoplasm.Treatment: arteria haemorrhoidalis perfusion chemotherapy, effect do not show and leave hospital.
Took Chinese medicine composition of the present invention 1 month, abdominal distention is greatly alleviated, CT: lump before has and reduces.Continue and obeyed Chinese medicine composition of the present invention 2 months, focus is about former 1/2 size, and idol has the mucus hemafecia, and diet increases, and malaise symptoms disappears substantially, and symptom is greatly taken on a new look.After 5 months, do not see focus continue clothes Chinese medicine composition of the present invention, every inspection is all normal, and spirit is better, and weight increase is followed up a case by regular visits to so far, and situation is stable.
7, money, man, 52 years old, engineer.
Main suit: recurrent diarrhea companion tenesmus 1 year.Disease is come passage of loose stools 4-5 time/day, companion's tenesmus, and paroxysmal abdominal pain just before increases the weight of, and alleviates after an action of the bowels.Angiography: inferior mesenteric artery sees that sigmoid arteries blood supply zone blood vessel increases, and tortuous, dense dying meets tumor and change.Pathological diagnosis: sigmoid colon tumor.Treatment row regional chemotherapy, obviously weak behind the first quarter moon because of muscle power, to feel sick, vomiting is to stop chemotherapy, the request Chinese traditional treatment.
Took Chinese medicine composition of the present invention 1 month, focus is significantly less, and all diseases alleviate.Continue and obeyed Chinese medicine composition of the present invention 3 months, focus is more preceding significantly to be reduced, and abdominal pain diarrhea stops, and malaise symptoms disappears substantially, and symptom is greatly taken on a new look.After June, focus disappears substantially continue clothes Chinese medicine composition of the present invention, and every inspection is all normal, resumes work, and patient health is not seen recurrence so far.
8, Zhao, man, 49 years old, manager.
Main suit: suffer from abdominal pain repeatedly, suffered from diarrhoea 3 years, increased the weight of to accompany hemafecia 3 months.Disease has paroxysmal abdominal pain, row's mucus loose stool 3-4 time/day, and stomachache can be alleviated after an action of the bowels.Chemical examination: just routine is a loose stool, the full visual field of erythrocyte, the occult blood positive.Intestinal mirror: rectal neoplasm.Angiography: the visible nearly oval blood vessel dyeing of superior rectal artery and sigmoid arteries radiography, superior rectal artery is tortuous to be increased slightly, meets rectal neoplasm blood for changing.
Took Chinese medicine composition of the present invention 1 month, abdominal pain diarrhea alleviates, and hemafecia reduces to some extent, and just 1-2 time/day, reexamine focus before has and reduces.Continue and obeyed Chinese medicine composition of the present invention 3 months, focus is about former 1/3 size, the stool molding, and idol has the mucus hemafecia, and diet increases, and malaise symptoms disappears substantially, and symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 5 months, every inspection is all normal, and focus disappears substantially, and patient's spirit is better followed up a case by regular visits to so far, and situation is stable.
9, Bao, man, 56 years old, professor.
Because intermittent diarrhea over the past half year, the time hemafecia is arranged, reason such as it is shapeless defecate, finds in Beijing large hospital inspection: multiple intestinal tumour, big or small 11 altogether.With requiring its operation of being in hospital,, fail to assent owing to the patient worries the health reason.
Health is become thin seriously when examining, and body weight descended about 10 jin in one month, and still was the continuation downward trend, diet, have a rest normal substantially.Take pharmaceutical composition of the present invention after 1 month, 2.2 kilograms of weight increase require its check, and the patient has no resolution because of work factor.After 6 months, check is found: intestinal tumour is invisible continue clothes pharmaceutical composition of the present invention, and stool is normal fully, and body weight increases to former state, and all are felt good.For consolidating curative effect, took pharmaceutical composition of the present invention again 4 months, things are as usual, and in the period of after this nearly 20, not having has recurrence.
Five, therapeutic outcome:
In the 63 routine cases of being accepted for medical treatment,, wherein cure 19 examples through treatment in 12 months, produce effects 25 examples, effective 17 examples, invalid 2 examples, total effective rate reaches 96 %.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment intestinal tumour patient.

Claims (4)

1. a Chinese medicine composition for the treatment of intestinal tumour is characterized in that: be made up of following bulk drugs: 30 parts of Squama Manis (processed), 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 150 parts of Semen Coiciss, 60 parts in Poria, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Trichosanthis, 20 parts of Rhizoma Coptidis, 15 parts of Hirudos, 50 parts of Radix Notoginseng, 100 parts of Pericarpium Citri Reticulataes, 50 parts of the Radix Aucklandiae, 100 parts of Rhizoma Cyperi, 50 parts of the Radix Paeoniae Albas, 20 parts of Platycladi Cacumen carbonisatum, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 100 parts of Massa Medicata Fermentata preparatas, 20 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Amomis, 100 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Radix Rehmanniae Preparata, 20 parts of Carapax Trionycis (processed), 20 parts of Carapax Et Plastrum Testudinis (processed), 30 parts of Semen Raphanis, 30 parts in Radix Rubiae, 20 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 20 parts of Aspongopuss, 30 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 30 parts of Rhizoma Chuanxiongs, 20 parts of charred Radix Sanguisorbae.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the method for Chinese medicinal according to routine is prepared into any oral formulations commonly used.
3. according to the described Chinese medicine composition of claim 2, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule.
4. the application of any described Chinese medicine composition of claim 1~3 in preparation treatment intestinal tumour medicine.
CN2010101153557A 2010-02-28 2010-02-28 Traditional Chinese medicine compound for treating intestinal tumor Expired - Fee Related CN101780254B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101153557A CN101780254B (en) 2010-02-28 2010-02-28 Traditional Chinese medicine compound for treating intestinal tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101153557A CN101780254B (en) 2010-02-28 2010-02-28 Traditional Chinese medicine compound for treating intestinal tumor

Publications (2)

Publication Number Publication Date
CN101780254A CN101780254A (en) 2010-07-21
CN101780254B true CN101780254B (en) 2011-08-31

Family

ID=42520478

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101153557A Expired - Fee Related CN101780254B (en) 2010-02-28 2010-02-28 Traditional Chinese medicine compound for treating intestinal tumor

Country Status (1)

Country Link
CN (1) CN101780254B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085335B (en) * 2011-01-20 2012-02-22 谭振花 Traditional Chinese medicine enema for treating ulcerative colitis
CN102657823B (en) * 2011-12-01 2013-03-06 成都地奥集团天府药业股份有限公司 Traditional Chinese medicine composition with anticancer effect and preparation method and detection method thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102652824B (en) * 2012-03-02 2013-10-16 济南伟传信息技术有限公司 Traditional Chinese medicine composition for treating acute enteritis
CN102743738B (en) * 2012-07-27 2014-01-08 赵晓霞 External use navel spreading sparadrap for treating gastrointestinal dysfunction
CN103386024B (en) * 2013-06-19 2014-10-22 孙伟 Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof
CN103638384B (en) * 2013-12-10 2016-03-23 青岛市海慈医疗集团 A kind of pharmaceutical composition of enema treatment cancer patients abdominal distention and application thereof
CN103768543B (en) * 2014-03-03 2016-02-03 陈海林 A kind of medicament for the treatment of bladder cancer
CN105920534A (en) * 2016-06-16 2016-09-07 陕西中医药大学附属医院 Traditional Chinese medicine composition for treating digestive tract malignant tumors and preparation of composition
CN109673856A (en) * 2018-12-29 2019-04-26 广西康佳龙农牧集团有限公司 It is a kind of prevent and treat piglet yellow-white dysentery Synbiotic feed additive and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1486740A (en) * 2003-08-28 2004-04-07 肖厚杰 Chinese medicine composition for treating cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1486740A (en) * 2003-08-28 2004-04-07 肖厚杰 Chinese medicine composition for treating cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
林倩雯等.子宫肌瘤的中医治疗概况.《辽宁中医药大学学报》.2007,第9卷(第05期),62-63. *
王会玲.中医药对肿瘤辅助治疗的进展.《陕西中医》.1994,第15卷(第04期), *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085335B (en) * 2011-01-20 2012-02-22 谭振花 Traditional Chinese medicine enema for treating ulcerative colitis
CN102657823B (en) * 2011-12-01 2013-03-06 成都地奥集团天府药业股份有限公司 Traditional Chinese medicine composition with anticancer effect and preparation method and detection method thereof

Also Published As

Publication number Publication date
CN101780254A (en) 2010-07-21

Similar Documents

Publication Publication Date Title
CN101780254B (en) Traditional Chinese medicine compound for treating intestinal tumor
CN101780247B (en) Traditional Chinese medicine composition for treating acute enteritis and preparation method thereof
CN101773633B (en) Chinese medicine composition for treating gastric ulcer
CN101757542B (en) Traditional Chinese medicine composition for treating colonitis and preparation method
CN101850086B (en) Chinese medicinal composition for treating symptom of gallstones and preparation method thereof
CN101757598B (en) Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof
CN101757567B (en) Traditional Chinese medicine composition for treating rectal cancer and preparation method thereof
CN101766790B (en) Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof
CN101869691B (en) Chinese medicinal composition for treating dysmenorrhea and preparation method thereof
CN101785847A (en) Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof
CN101711851B (en) Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof
CN101757566A (en) Traditional Chinese medicine composition for treating colon cancer and preparation method thereof
CN101816742A (en) Chinese medicinal composition for treating hemorrhoids and preparation method thereof
CN101766789B (en) Chinese medicine composite for treating appendicitis and preparation method thereof
CN101966313A (en) Chinese medicinal composition for treating female infertility and preparation method thereof
CN101966322A (en) Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof
CN101972445A (en) Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof
CN101773634A (en) Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof
CN101757562B (en) Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof
CN101961480A (en) Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof
CN101810835A (en) Chinese medicinal composition for treating purpura and preparation method thereof
CN101780252B (en) Traditional Chinese medicine compound for treating intestinal obstruction and preparation method thereof
CN101773648B (en) Chinese medicine composition for treating gastric cancer and preparation method thereof
CN101810823B (en) Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine
CN101785846A (en) Traditional Chinese medicine combination and preparation method for intestinal depression disease treatment

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110831

Termination date: 20130228